|
Drug Therapy
Citations 51-60 of 200 total displayed.
|
Past content
(since May 1999):
|
- Editorials
Central Nervous System Immune Surveillance: On Natalizumab, Dendritic Cells, and Dangerous Immune Privilege
- Burkhard Becher
Arch Neurol 2008; 65: 1566-1567.
[Extract]
[Full text]
[PDF]
- Original Contributions
Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab
- Maria del Pilar Martin; Petra D. Cravens; Ryan Winger; Elliot M. Frohman; Michael K. Racke; Todd N. Eagar; Scott S. Zamvil; Martin S. Weber; Bernhard Hemmer; Nitin J. Karandikar; B. K. Kleinschmidt-DeMasters; Olaf Stüve
Arch Neurol 2008; 65: 1596-1603.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
- Roberto Cilia; Chiara Siri; Giorgio Marotta; Ioannis U. Isaias; Danilo De Gaspari; Margherita Canesi; Gianni Pezzoli; Angelo Antonini
Arch Neurol 2008; 65: 1604-1611.
[Abstract]
[Full text]
[PDF]
- Observations
Natalizumab Use in Pediatric Multiple Sclerosis
- Peter Huppke; Wiebke Stark; Claudia Zürcher; Brenda Huppke; Wolfgang Brück; Jutta Gärtner
Arch Neurol 2008; 65: 1655-1658.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Heterogeneity in Response to Interferon Beta in Patients With Multiple Sclerosis: A 3-Year Monthly Imaging Study
- Annie W. Chiu; Nancy Richert; Mary Ehrmantraut; Joan Ohayon; Shiva Gupta; Giuseppe Bomboi; Deeya Gaindh; Fredric K. Cantor; Joseph A. Frank; Henry F. McFarland; Francesca Bagnato
Arch Neurol 66.1.noc80047.
[Abstract]
[Full text]
[]
- Editorials
Fine-tuning the Homeostasis of Regulatory T Cells: New Mechanism of Immunomodulatory Therapy in Multiple Sclerosis
- Harald H. Hofstetter; Olaf Stüve; Hans-Peter Hartung
Arch Neurol 2008; 65: 1417-1418.
[Extract]
[Full text]
[PDF]
- Neurological Reviews
Management of and Prognosis With Medulloblastoma: Therapy at a Crossroads
- Roger J. Packer; Gilbert Vezina
Arch Neurol 2008; 65: 1419-1424.
[Abstract]
[Full text]
[PDF]
- Neurological Reviews
Review of Tissue Plasminogen Activator, Ischemic Stroke, and Potential Legal Issues
- Bryan A. Liang; Robert Lew; Justin A. Zivin
Arch Neurol 2008; 65: 1429-1433.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Interferon Beta–Induced Restoration of Regulatory T-Cell Function in Multiple Sclerosis Is Prompted by an Increase in Newly Generated Naive Regulatory T Cells
- Mirjam Korporal; Juergen Haas; Bettina Balint; Benedikt Fritzsching; Alexander Schwarz; Sigrid Moeller; Brigitte Fritz; Elisabeth Suri-Payer; Brigitte Wildemann
Arch Neurol 2008; 65: 1434-1439.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Treatment of Neuromyelitis Optica With Rituximab: Retrospective Analysis of 25 Patients
- Anu Jacob; Brian G. Weinshenker; Ivo Violich; Nancy McLinskey; Lauren Krupp; Robert J. Fox; Dean M. Wingerchuk; Mike Boggild; Cris S. Constantinescu; Aaron Miller; Tracy De Angelis; Marcelo Matiello; Bruce A. C. Cree
Arch Neurol 2008; 65: 1443-1448.
[Abstract]
[Full text]
[PDF]
|
|
